 | • レポートコード：GIR-23F3748 • 出版社/出版日：GlobalInfoResearch / 2023年2月 • レポート形態：英文、PDF、123ページ • 納品方法：Eメール（2~3営業日） • 産業分類：医薬品 |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥783,000 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,044,000 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 「Global Anti-Infective Drugs Market」レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。 グローバルインフォリサーチ社（香港）の最新の調査によると、世界の抗感染薬の市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。 抗感染薬市場はタイプ（種類）とアプリケーション（用途）によって区分されます。2017年～2028年において、量と金額の観点からタイプ別およびアプリケーション別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。 タイプ別セグメントは次を対象にします。 ・OTC、Rxドラッグ アプリケーション別セグメントは次のように区分されます。 ・病院、ドラッグストア、その他 世界の抗感染薬市場の主要なマーケットプレーヤーは以下のとおりです。 ・GlaxoSmithKline、Merck、Pfizer、Novartis AG、Gilead Sciences、Abbott、Wyeth、Sanofi-Aventis、Bristol-Myers Squibb、Johnson、Roche Pharma AG、Nanosphere、NanoViricides、Novabay Pharmaceuticals、Obetech、Optimer Pharmaceuticals、Basilea Pharmaceutica AG、Daiichi Sankyo、MerLion Pharma、Theravance 地域別セグメントは次の地域・国を対象にします。 ・北米市場（米国、カナダ、メキシコ） ・ヨーロッパ市場（ドイツ、フランス、イギリス、ロシア、イタリア） ・アジア太平洋市場（日本、中国、韓国、インド、東南アジア、オーストラリア） ・南米市場（ブラジル、アルゼンチン、コロンビア） ・中東・アフリカ市場（サウジアラビア、UAE、エジプト、南アフリカ） ***** 目次(一部) ***** ・市場概要 - 抗感染薬の概要 - タイプ別分析（2017年vs2021年vs2028年）：OTC、Rxドラッグ - アプリケーション別分析（2017年vs2021年vs2028年）：病院、ドラッグストア、その他 - 世界の抗感染薬市場規模・予測 - 世界の抗感染薬生産能力分析 - 市場の成長要因・阻害要因・動向 ・メーカー情報（企業概要、製品概要、販売量、価格、売上） - GlaxoSmithKline、Merck、Pfizer、Novartis AG、Gilead Sciences、Abbott、Wyeth、Sanofi-Aventis、Bristol-Myers Squibb、Johnson、Roche Pharma AG、Nanosphere、NanoViricides、Novabay Pharmaceuticals、Obetech、Optimer Pharmaceuticals、Basilea Pharmaceutica AG、Daiichi Sankyo、MerLion Pharma、Theravance ・メーカー別市場シェア・市場集中度 ・地域別市場分析2017年-2028年 ・タイプ別分析2017年-2028年：OTC、Rxドラッグ ・アプリケーション別分析2017年-2028年：病院、ドラッグストア、その他 ・抗感染薬の北米市場分析 - 抗感染薬の北米市場：タイプ別市場規模2017年-2028年 - 抗感染薬の北米市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：アメリカ、カナダ、メキシコなど ・抗感染薬のヨーロッパ市場分析 - ：抗感染薬のヨーロッパ市場：タイプ別市場規模2017年-2028年 - ：抗感染薬のヨーロッパ市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど ・抗感染薬のアジア太平洋市場分析 - 抗感染薬のアジア太平洋市場：タイプ別市場規模2017年-2028年 - 抗感染薬のアジア太平洋市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど ・抗感染薬の南米市場分析 - 抗感染薬の南米市場：タイプ別市場規模2017年-2028年 - 抗感染薬の南米市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：ブラジル、アルゼンチンなど ・抗感染薬の中東・アフリカ市場分析 - 抗感染薬の中東・アフリカ市場：タイプ別市場規模2017年-2028年 - 抗感染薬の中東・アフリカ市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど ・原材料および産業チェーン ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Anti-Infective Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Anti-Infective Drugs market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Hospital accounting for % of the Anti-Infective Drugs global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While OTC segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Anti-Infective Drugs include GlaxoSmithKline, Merck, Pfizer, Novartis AG, and Gilead Sciences, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Anti-Infective Drugs market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
OTC
Rx Drugs
Market segment by Application can be divided into
Hospital
Drugs Store
Other
The key market players for global Anti-Infective Drugs market are listed below:
GlaxoSmithKline
Merck
Pfizer
Novartis AG
Gilead Sciences
Abbott
Wyeth
Sanofi-Aventis
Bristol-Myers Squibb
Johnson
Roche Pharma AG
Nanosphere
NanoViricides
Novabay Pharmaceuticals
Obetech
Optimer Pharmaceuticals
Basilea Pharmaceutica AG
Daiichi Sankyo
MerLion Pharma
Theravance
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Anti-Infective Drugs product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Anti-Infective Drugs, with price, sales, revenue and global market share of Anti-Infective Drugs from 2019 to 2022.
Chapter 3, the Anti-Infective Drugs competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Anti-Infective Drugs breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Anti-Infective Drugs market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Anti-Infective Drugs.
Chapter 13, 14, and 15, to describe Anti-Infective Drugs sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Anti-Infective Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Anti-Infective Drugs Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 OTC
1.2.3 Rx Drugs
1.3 Market Analysis by Application
1.3.1 Overview: Global Anti-Infective Drugs Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Hospital
1.3.3 Drugs Store
1.3.4 Other
1.4 Global Anti-Infective Drugs Market Size & Forecast
1.4.1 Global Anti-Infective Drugs Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Anti-Infective Drugs Sales in Volume (2017-2028)
1.4.3 Global Anti-Infective Drugs Price (2017-2028)
1.5 Global Anti-Infective Drugs Production Capacity Analysis
1.5.1 Global Anti-Infective Drugs Total Production Capacity (2017-2028)
1.5.2 Global Anti-Infective Drugs Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Anti-Infective Drugs Market Drivers
1.6.2 Anti-Infective Drugs Market Restraints
1.6.3 Anti-Infective Drugs Trends Analysis
2 Manufacturers Profiles
2.1 GlaxoSmithKline
2.1.1 GlaxoSmithKline Details
2.1.2 GlaxoSmithKline Major Business
2.1.3 GlaxoSmithKline Anti-Infective Drugs Product and Services
2.1.4 GlaxoSmithKline Anti-Infective Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Merck
2.2.1 Merck Details
2.2.2 Merck Major Business
2.2.3 Merck Anti-Infective Drugs Product and Services
2.2.4 Merck Anti-Infective Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Pfizer
2.3.1 Pfizer Details
2.3.2 Pfizer Major Business
2.3.3 Pfizer Anti-Infective Drugs Product and Services
2.3.4 Pfizer Anti-Infective Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Novartis AG
2.4.1 Novartis AG Details
2.4.2 Novartis AG Major Business
2.4.3 Novartis AG Anti-Infective Drugs Product and Services
2.4.4 Novartis AG Anti-Infective Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Gilead Sciences
2.5.1 Gilead Sciences Details
2.5.2 Gilead Sciences Major Business
2.5.3 Gilead Sciences Anti-Infective Drugs Product and Services
2.5.4 Gilead Sciences Anti-Infective Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Abbott
2.6.1 Abbott Details
2.6.2 Abbott Major Business
2.6.3 Abbott Anti-Infective Drugs Product and Services
2.6.4 Abbott Anti-Infective Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Wyeth
2.7.1 Wyeth Details
2.7.2 Wyeth Major Business
2.7.3 Wyeth Anti-Infective Drugs Product and Services
2.7.4 Wyeth Anti-Infective Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Sanofi-Aventis
2.8.1 Sanofi-Aventis Details
2.8.2 Sanofi-Aventis Major Business
2.8.3 Sanofi-Aventis Anti-Infective Drugs Product and Services
2.8.4 Sanofi-Aventis Anti-Infective Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Bristol-Myers Squibb
2.9.1 Bristol-Myers Squibb Details
2.9.2 Bristol-Myers Squibb Major Business
2.9.3 Bristol-Myers Squibb Anti-Infective Drugs Product and Services
2.9.4 Bristol-Myers Squibb Anti-Infective Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 Johnson
2.10.1 Johnson Details
2.10.2 Johnson Major Business
2.10.3 Johnson Anti-Infective Drugs Product and Services
2.10.4 Johnson Anti-Infective Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11 Roche Pharma AG
2.11.1 Roche Pharma AG Details
2.11.2 Roche Pharma AG Major Business
2.11.3 Roche Pharma AG Anti-Infective Drugs Product and Services
2.11.4 Roche Pharma AG Anti-Infective Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12 Nanosphere
2.12.1 Nanosphere Details
2.12.2 Nanosphere Major Business
2.12.3 Nanosphere Anti-Infective Drugs Product and Services
2.12.4 Nanosphere Anti-Infective Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13 NanoViricides
2.13.1 NanoViricides Details
2.13.2 NanoViricides Major Business
2.13.3 NanoViricides Anti-Infective Drugs Product and Services
2.13.4 NanoViricides Anti-Infective Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.14 Novabay Pharmaceuticals
2.14.1 Novabay Pharmaceuticals Details
2.14.2 Novabay Pharmaceuticals Major Business
2.14.3 Novabay Pharmaceuticals Anti-Infective Drugs Product and Services
2.14.4 Novabay Pharmaceuticals Anti-Infective Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.15 Obetech
2.15.1 Obetech Details
2.15.2 Obetech Major Business
2.15.3 Obetech Anti-Infective Drugs Product and Services
2.15.4 Obetech Anti-Infective Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.16 Optimer Pharmaceuticals
2.16.1 Optimer Pharmaceuticals Details
2.16.2 Optimer Pharmaceuticals Major Business
2.16.3 Optimer Pharmaceuticals Anti-Infective Drugs Product and Services
2.16.4 Optimer Pharmaceuticals Anti-Infective Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.17 Basilea Pharmaceutica AG
2.17.1 Basilea Pharmaceutica AG Details
2.17.2 Basilea Pharmaceutica AG Major Business
2.17.3 Basilea Pharmaceutica AG Anti-Infective Drugs Product and Services
2.17.4 Basilea Pharmaceutica AG Anti-Infective Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.18 Daiichi Sankyo
2.18.1 Daiichi Sankyo Details
2.18.2 Daiichi Sankyo Major Business
2.18.3 Daiichi Sankyo Anti-Infective Drugs Product and Services
2.18.4 Daiichi Sankyo Anti-Infective Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.19 MerLion Pharma
2.19.1 MerLion Pharma Details
2.19.2 MerLion Pharma Major Business
2.19.3 MerLion Pharma Anti-Infective Drugs Product and Services
2.19.4 MerLion Pharma Anti-Infective Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.20 Theravance
2.20.1 Theravance Details
2.20.2 Theravance Major Business
2.20.3 Theravance Anti-Infective Drugs Product and Services
2.20.4 Theravance Anti-Infective Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Anti-Infective Drugs Breakdown Data by Manufacturer
3.1 Global Anti-Infective Drugs Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Anti-Infective Drugs Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Anti-Infective Drugs
3.4 Market Concentration Rate
3.4.1 Top 3 Anti-Infective Drugs Manufacturer Market Share in 2021
3.4.2 Top 6 Anti-Infective Drugs Manufacturer Market Share in 2021
3.5 Global Anti-Infective Drugs Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Anti-Infective Drugs Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Anti-Infective Drugs Market Size by Region
4.1.1 Global Anti-Infective Drugs Sales in Volume by Region (2017-2028)
4.1.2 Global Anti-Infective Drugs Revenue by Region (2017-2028)
4.2 North America Anti-Infective Drugs Revenue (2017-2028)
4.3 Europe Anti-Infective Drugs Revenue (2017-2028)
4.4 Asia-Pacific Anti-Infective Drugs Revenue (2017-2028)
4.5 South America Anti-Infective Drugs Revenue (2017-2028)
4.6 Middle East and Africa Anti-Infective Drugs Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Anti-Infective Drugs Sales in Volume by Type (2017-2028)
5.2 Global Anti-Infective Drugs Revenue by Type (2017-2028)
5.3 Global Anti-Infective Drugs Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Anti-Infective Drugs Sales in Volume by Application (2017-2028)
6.2 Global Anti-Infective Drugs Revenue by Application (2017-2028)
6.3 Global Anti-Infective Drugs Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Anti-Infective Drugs Sales by Type (2017-2028)
7.2 North America Anti-Infective Drugs Sales by Application (2017-2028)
7.3 North America Anti-Infective Drugs Market Size by Country
7.3.1 North America Anti-Infective Drugs Sales in Volume by Country (2017-2028)
7.3.2 North America Anti-Infective Drugs Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Anti-Infective Drugs Sales by Type (2017-2028)
8.2 Europe Anti-Infective Drugs Sales by Application (2017-2028)
8.3 Europe Anti-Infective Drugs Market Size by Country
8.3.1 Europe Anti-Infective Drugs Sales in Volume by Country (2017-2028)
8.3.2 Europe Anti-Infective Drugs Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Anti-Infective Drugs Sales by Type (2017-2028)
9.2 Asia-Pacific Anti-Infective Drugs Sales by Application (2017-2028)
9.3 Asia-Pacific Anti-Infective Drugs Market Size by Region
9.3.1 Asia-Pacific Anti-Infective Drugs Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Anti-Infective Drugs Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Anti-Infective Drugs Sales by Type (2017-2028)
10.2 South America Anti-Infective Drugs Sales by Application (2017-2028)
10.3 South America Anti-Infective Drugs Market Size by Country
10.3.1 South America Anti-Infective Drugs Sales in Volume by Country (2017-2028)
10.3.2 South America Anti-Infective Drugs Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Anti-Infective Drugs Sales by Type (2017-2028)
11.2 Middle East & Africa Anti-Infective Drugs Sales by Application (2017-2028)
11.3 Middle East & Africa Anti-Infective Drugs Market Size by Country
11.3.1 Middle East & Africa Anti-Infective Drugs Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Anti-Infective Drugs Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Anti-Infective Drugs and Key Manufacturers
12.2 Manufacturing Costs Percentage of Anti-Infective Drugs
12.3 Anti-Infective Drugs Production Process
12.4 Anti-Infective Drugs Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Anti-Infective Drugs Typical Distributors
13.3 Anti-Infective Drugs Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer
Table 1. Global Anti-Infective Drugs Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Anti-Infective Drugs Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table 4. GlaxoSmithKline Major Business
Table 5. GlaxoSmithKline Anti-Infective Drugs Product and Services
Table 6. GlaxoSmithKline Anti-Infective Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Merck Basic Information, Manufacturing Base and Competitors
Table 8. Merck Major Business
Table 9. Merck Anti-Infective Drugs Product and Services
Table 10. Merck Anti-Infective Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Pfizer Basic Information, Manufacturing Base and Competitors
Table 12. Pfizer Major Business
Table 13. Pfizer Anti-Infective Drugs Product and Services
Table 14. Pfizer Anti-Infective Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Novartis AG Basic Information, Manufacturing Base and Competitors
Table 16. Novartis AG Major Business
Table 17. Novartis AG Anti-Infective Drugs Product and Services
Table 18. Novartis AG Anti-Infective Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Gilead Sciences Basic Information, Manufacturing Base and Competitors
Table 20. Gilead Sciences Major Business
Table 21. Gilead Sciences Anti-Infective Drugs Product and Services
Table 22. Gilead Sciences Anti-Infective Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Abbott Basic Information, Manufacturing Base and Competitors
Table 24. Abbott Major Business
Table 25. Abbott Anti-Infective Drugs Product and Services
Table 26. Abbott Anti-Infective Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Wyeth Basic Information, Manufacturing Base and Competitors
Table 28. Wyeth Major Business
Table 29. Wyeth Anti-Infective Drugs Product and Services
Table 30. Wyeth Anti-Infective Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. Sanofi-Aventis Basic Information, Manufacturing Base and Competitors
Table 32. Sanofi-Aventis Major Business
Table 33. Sanofi-Aventis Anti-Infective Drugs Product and Services
Table 34. Sanofi-Aventis Anti-Infective Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. Bristol-Myers Squibb Basic Information, Manufacturing Base and Competitors
Table 36. Bristol-Myers Squibb Major Business
Table 37. Bristol-Myers Squibb Anti-Infective Drugs Product and Services
Table 38. Bristol-Myers Squibb Anti-Infective Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 39. Johnson Basic Information, Manufacturing Base and Competitors
Table 40. Johnson Major Business
Table 41. Johnson Anti-Infective Drugs Product and Services
Table 42. Johnson Anti-Infective Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 43. Roche Pharma AG Basic Information, Manufacturing Base and Competitors
Table 44. Roche Pharma AG Major Business
Table 45. Roche Pharma AG Anti-Infective Drugs Product and Services
Table 46. Roche Pharma AG Anti-Infective Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 47. Nanosphere Basic Information, Manufacturing Base and Competitors
Table 48. Nanosphere Major Business
Table 49. Nanosphere Anti-Infective Drugs Product and Services
Table 50. Nanosphere Anti-Infective Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 51. NanoViricides Basic Information, Manufacturing Base and Competitors
Table 52. NanoViricides Major Business
Table 53. NanoViricides Anti-Infective Drugs Product and Services
Table 54. NanoViricides Anti-Infective Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 55. Novabay Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 56. Novabay Pharmaceuticals Major Business
Table 57. Novabay Pharmaceuticals Anti-Infective Drugs Product and Services
Table 58. Novabay Pharmaceuticals Anti-Infective Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 59. Obetech Basic Information, Manufacturing Base and Competitors
Table 60. Obetech Major Business
Table 61. Obetech Anti-Infective Drugs Product and Services
Table 62. Obetech Anti-Infective Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 63. Optimer Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 64. Optimer Pharmaceuticals Major Business
Table 65. Optimer Pharmaceuticals Anti-Infective Drugs Product and Services
Table 66. Optimer Pharmaceuticals Anti-Infective Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 67. Basilea Pharmaceutica AG Basic Information, Manufacturing Base and Competitors
Table 68. Basilea Pharmaceutica AG Major Business
Table 69. Basilea Pharmaceutica AG Anti-Infective Drugs Product and Services
Table 70. Basilea Pharmaceutica AG Anti-Infective Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 71. Daiichi Sankyo Basic Information, Manufacturing Base and Competitors
Table 72. Daiichi Sankyo Major Business
Table 73. Daiichi Sankyo Anti-Infective Drugs Product and Services
Table 74. Daiichi Sankyo Anti-Infective Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 75. MerLion Pharma Basic Information, Manufacturing Base and Competitors
Table 76. MerLion Pharma Major Business
Table 77. MerLion Pharma Anti-Infective Drugs Product and Services
Table 78. MerLion Pharma Anti-Infective Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 79. Theravance Basic Information, Manufacturing Base and Competitors
Table 80. Theravance Major Business
Table 81. Theravance Anti-Infective Drugs Product and Services
Table 82. Theravance Anti-Infective Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 83. Global Anti-Infective Drugs Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)
Table 84. Global Anti-Infective Drugs Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 85. Market Position of Manufacturers in Anti-Infective Drugs, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 86. Global Anti-Infective Drugs Production Capacity by Company, (K Units): 2020 VS 2021
Table 87. Head Office and Anti-Infective Drugs Production Site of Key Manufacturer
Table 88. Anti-Infective Drugs New Entrant and Capacity Expansion Plans
Table 89. Anti-Infective Drugs Mergers & Acquisitions in the Past Five Years
Table 90. Global Anti-Infective Drugs Sales by Region (2017-2022) & (K Units)
Table 91. Global Anti-Infective Drugs Sales by Region (2023-2028) & (K Units)
Table 92. Global Anti-Infective Drugs Revenue by Region (2017-2022) & (USD Million)
Table 93. Global Anti-Infective Drugs Revenue by Region (2023-2028) & (USD Million)
Table 94. Global Anti-Infective Drugs Sales by Type (2017-2022) & (K Units)
Table 95. Global Anti-Infective Drugs Sales by Type (2023-2028) & (K Units)
Table 96. Global Anti-Infective Drugs Revenue by Type (2017-2022) & (USD Million)
Table 97. Global Anti-Infective Drugs Revenue by Type (2023-2028) & (USD Million)
Table 98. Global Anti-Infective Drugs Price by Type (2017-2022) & (USD/Unit)
Table 99. Global Anti-Infective Drugs Price by Type (2023-2028) & (USD/Unit)
Table 100. Global Anti-Infective Drugs Sales by Application (2017-2022) & (K Units)
Table 101. Global Anti-Infective Drugs Sales by Application (2023-2028) & (K Units)
Table 102. Global Anti-Infective Drugs Revenue by Application (2017-2022) & (USD Million)
Table 103. Global Anti-Infective Drugs Revenue by Application (2023-2028) & (USD Million)
Table 104. Global Anti-Infective Drugs Price by Application (2017-2022) & (USD/Unit)
Table 105. Global Anti-Infective Drugs Price by Application (2023-2028) & (USD/Unit)
Table 106. North America Anti-Infective Drugs Sales by Country (2017-2022) & (K Units)
Table 107. North America Anti-Infective Drugs Sales by Country (2023-2028) & (K Units)
Table 108. North America Anti-Infective Drugs Revenue by Country (2017-2022) & (USD Million)
Table 109. North America Anti-Infective Drugs Revenue by Country (2023-2028) & (USD Million)
Table 110. North America Anti-Infective Drugs Sales by Type (2017-2022) & (K Units)
Table 111. North America Anti-Infective Drugs Sales by Type (2023-2028) & (K Units)
Table 112. North America Anti-Infective Drugs Sales by Application (2017-2022) & (K Units)
Table 113. North America Anti-Infective Drugs Sales by Application (2023-2028) & (K Units)
Table 114. Europe Anti-Infective Drugs Sales by Country (2017-2022) & (K Units)
Table 115. Europe Anti-Infective Drugs Sales by Country (2023-2028) & (K Units)
Table 116. Europe Anti-Infective Drugs Revenue by Country (2017-2022) & (USD Million)
Table 117. Europe Anti-Infective Drugs Revenue by Country (2023-2028) & (USD Million)
Table 118. Europe Anti-Infective Drugs Sales by Type (2017-2022) & (K Units)
Table 119. Europe Anti-Infective Drugs Sales by Type (2023-2028) & (K Units)
Table 120. Europe Anti-Infective Drugs Sales by Application (2017-2022) & (K Units)
Table 121. Europe Anti-Infective Drugs Sales by Application (2023-2028) & (K Units)
Table 122. Asia-Pacific Anti-Infective Drugs Sales by Region (2017-2022) & (K Units)
Table 123. Asia-Pacific Anti-Infective Drugs Sales by Region (2023-2028) & (K Units)
Table 124. Asia-Pacific Anti-Infective Drugs Revenue by Region (2017-2022) & (USD Million)
Table 125. Asia-Pacific Anti-Infective Drugs Revenue by Region (2023-2028) & (USD Million)
Table 126. Asia-Pacific Anti-Infective Drugs Sales by Type (2017-2022) & (K Units)
Table 127. Asia-Pacific Anti-Infective Drugs Sales by Type (2023-2028) & (K Units)
Table 128. Asia-Pacific Anti-Infective Drugs Sales by Application (2017-2022) & (K Units)
Table 129. Asia-Pacific Anti-Infective Drugs Sales by Application (2023-2028) & (K Units)
Table 130. South America Anti-Infective Drugs Sales by Country (2017-2022) & (K Units)
Table 131. South America Anti-Infective Drugs Sales by Country (2023-2028) & (K Units)
Table 132. South America Anti-Infective Drugs Revenue by Country (2017-2022) & (USD Million)
Table 133. South America Anti-Infective Drugs Revenue by Country (2023-2028) & (USD Million)
Table 134. South America Anti-Infective Drugs Sales by Type (2017-2022) & (K Units)
Table 135. South America Anti-Infective Drugs Sales by Type (2023-2028) & (K Units)
Table 136. South America Anti-Infective Drugs Sales by Application (2017-2022) & (K Units)
Table 137. South America Anti-Infective Drugs Sales by Application (2023-2028) & (K Units)
Table 138. Middle East & Africa Anti-Infective Drugs Sales by Region (2017-2022) & (K Units)
Table 139. Middle East & Africa Anti-Infective Drugs Sales by Region (2023-2028) & (K Units)
Table 140. Middle East & Africa Anti-Infective Drugs Revenue by Region (2017-2022) & (USD Million)
Table 141. Middle East & Africa Anti-Infective Drugs Revenue by Region (2023-2028) & (USD Million)
Table 142. Middle East & Africa Anti-Infective Drugs Sales by Type (2017-2022) & (K Units)
Table 143. Middle East & Africa Anti-Infective Drugs Sales by Type (2023-2028) & (K Units)
Table 144. Middle East & Africa Anti-Infective Drugs Sales by Application (2017-2022) & (K Units)
Table 145. Middle East & Africa Anti-Infective Drugs Sales by Application (2023-2028) & (K Units)
Table 146. Anti-Infective Drugs Raw Material
Table 147. Key Manufacturers of Anti-Infective Drugs Raw Materials
Table 148. Direct Channel Pros & Cons
Table 149. Indirect Channel Pros & Cons
Table 150. Anti-Infective Drugs Typical Distributors
Table 151. Anti-Infective Drugs Typical Customers
List of Figures
Figure 1. Anti-Infective Drugs Picture
Figure 2. Global Anti-Infective Drugs Revenue Market Share by Type in 2021
Figure 3. OTC
Figure 4. Rx Drugs
Figure 5. Global Anti-Infective Drugs Revenue Market Share by Application in 2021
Figure 6. Hospital
Figure 7. Drugs Store
Figure 8. Other
Figure 9. Global Anti-Infective Drugs Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028
Figure 10. Global Anti-Infective Drugs Revenue and Forecast (2017-2028) & (USD Million)
Figure 11. Global Anti-Infective Drugs Sales (2017-2028) & (K Units)
Figure 12. Global Anti-Infective Drugs Price (2017-2028) & (USD/Unit)
Figure 13. Global Anti-Infective Drugs Production Capacity (2017-2028) & (K Units)
Figure 14. Global Anti-Infective Drugs Production Capacity by Geographic Region: 2022 VS 2028
Figure 15. Anti-Infective Drugs Market Drivers
Figure 16. Anti-Infective Drugs Market Restraints
Figure 17. Anti-Infective Drugs Market Trends
Figure 18. Global Anti-Infective Drugs Sales Market Share by Manufacturer in 2021
Figure 19. Global Anti-Infective Drugs Revenue Market Share by Manufacturer in 2021
Figure 20. Anti-Infective Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 21. Top 3 Anti-Infective Drugs Manufacturer (Revenue) Market Share in 2021
Figure 22. Top 6 Anti-Infective Drugs Manufacturer (Revenue) Market Share in 2021
Figure 23. Global Anti-Infective Drugs Sales Market Share by Region (2017-2028)
Figure 24. Global Anti-Infective Drugs Revenue Market Share by Region (2017-2028)
Figure 25. North America Anti-Infective Drugs Revenue (2017-2028) & (USD Million)
Figure 26. Europe Anti-Infective Drugs Revenue (2017-2028) & (USD Million)
Figure 27. Asia-Pacific Anti-Infective Drugs Revenue (2017-2028) & (USD Million)
Figure 28. South America Anti-Infective Drugs Revenue (2017-2028) & (USD Million)
Figure 29. Middle East & Africa Anti-Infective Drugs Revenue (2017-2028) & (USD Million)
Figure 30. Global Anti-Infective Drugs Sales Market Share by Type (2017-2028)
Figure 31. Global Anti-Infective Drugs Revenue Market Share by Type (2017-2028)
Figure 32. Global Anti-Infective Drugs Price by Type (2017-2028) & (USD/Unit)
Figure 33. Global Anti-Infective Drugs Sales Market Share by Application (2017-2028)
Figure 34. Global Anti-Infective Drugs Revenue Market Share by Application (2017-2028)
Figure 35. Global Anti-Infective Drugs Price by Application (2017-2028) & (USD/Unit)
Figure 36. North America Anti-Infective Drugs Sales Market Share by Type (2017-2028)
Figure 37. North America Anti-Infective Drugs Sales Market Share by Application (2017-2028)
Figure 38. North America Anti-Infective Drugs Sales Market Share by Country (2017-2028)
Figure 39. North America Anti-Infective Drugs Revenue Market Share by Country (2017-2028)
Figure 40. United States Anti-Infective Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 41. Canada Anti-Infective Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 42. Mexico Anti-Infective Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 43. Europe Anti-Infective Drugs Sales Market Share by Type (2017-2028)
Figure 44. Europe Anti-Infective Drugs Sales Market Share by Application (2017-2028)
Figure 45. Europe Anti-Infective Drugs Sales Market Share by Country (2017-2028)
Figure 46. Europe Anti-Infective Drugs Revenue Market Share by Country (2017-2028)
Figure 47. Germany Anti-Infective Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 48. France Anti-Infective Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. United Kingdom Anti-Infective Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. Russia Anti-Infective Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Italy Anti-Infective Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Asia-Pacific Anti-Infective Drugs Sales Market Share by Region (2017-2028)
Figure 53. Asia-Pacific Anti-Infective Drugs Sales Market Share by Application (2017-2028)
Figure 54. Asia-Pacific Anti-Infective Drugs Sales Market Share by Region (2017-2028)
Figure 55. Asia-Pacific Anti-Infective Drugs Revenue Market Share by Region (2017-2028)
Figure 56. China Anti-Infective Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Japan Anti-Infective Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. Korea Anti-Infective Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. India Anti-Infective Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Southeast Asia Anti-Infective Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Australia Anti-Infective Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. South America Anti-Infective Drugs Sales Market Share by Type (2017-2028)
Figure 63. South America Anti-Infective Drugs Sales Market Share by Application (2017-2028)
Figure 64. South America Anti-Infective Drugs Sales Market Share by Country (2017-2028)
Figure 65. South America Anti-Infective Drugs Revenue Market Share by Country (2017-2028)
Figure 66. Brazil Anti-Infective Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. Argentina Anti-Infective Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. Middle East & Africa Anti-Infective Drugs Sales Market Share by Type (2017-2028)
Figure 69. Middle East & Africa Anti-Infective Drugs Sales Market Share by Application (2017-2028)
Figure 70. Middle East & Africa Anti-Infective Drugs Sales Market Share by Region (2017-2028)
Figure 71. Middle East & Africa Anti-Infective Drugs Revenue Market Share by Region (2017-2028)
Figure 72. Turkey Anti-Infective Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. Egypt Anti-Infective Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. Saudi Arabia Anti-Infective Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. South Africa Anti-Infective Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. Manufacturing Cost Structure Analysis of Anti-Infective Drugs in 2021
Figure 77. Manufacturing Process Analysis of Anti-Infective Drugs
Figure 78. Anti-Infective Drugs Industrial Chain
Figure 79. Sales Channel: Direct Channel vs Indirect Channel
Figure 80. Methodology
Figure 81. Research Process and Data Source